Patents by Inventor Hans-Rudolf Mueller

Hans-Rudolf Mueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7090770
    Abstract: The invention relates to a filter cloth for a filter press and to a method for producing said filter cloth. The inventive filter cloth has a filtration section through which the filtrate reaches a filter element of the filter press, and an edging section which rests against the edge of the filter element. The filtration area is provided with a cloth that differs from that of the edging section. The filtration area is woven from monofil yarns while multifil yarns are woven into the edging section.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: August 15, 2006
    Assignee: Sefar AG
    Inventors: Hans Rudolf Mueller, Christoph Maurer
  • Patent number: 6849735
    Abstract: An improved method of synthesis of a 9-substituted hypoxanthine derivative comprises the steps of: (1) reacting aminocyanacetamide with triethyl orthoformate to form an imidoester derivative of aminocyanacetamide; (2) forming a compound having a reactive amino group on a hydrocarbyl moiety, the hydrocarbyl moiety being linked through an amide group to a physiologically active moiety or an esterified derivative of a physiologically active moiety including therein an esterified benzoyl group; (3) reacting the imidoester with the compound having the reactive amino group on the hydrocarbyl moiety to form a derivative of aminoimidazole-4-carboxamide substituted at the 1-position with a hydrocarbyl moiety linked through an amide group to a physiologically active moiety including therein an optionally esterified benzoyl group; (4) forming the six-membered heterocyclic ring of the purine moiety of the hypoxanthine by reacting the derivative of 5-aminoimidazole-4-carboxamide formed in step (3) with triethyl orthoforma
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: February 1, 2005
    Assignee: Merck Eprova AG
    Inventors: Alvin J. Glasky, Heinrich Bollinger, Hans Rudolf Müller
  • Patent number: 6596721
    Abstract: Pure and extremely stable crystalline (6R)-tetrahydrofolic acids, absolutely inert even when exposed to air and elevated temperature without stabilizers being added, are prepared by a crystallization process at a pH of ≧2.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: July 22, 2003
    Assignee: Eprova AG
    Inventors: Hans Rudolf Müller, Martin Ulmann, Rudolf Moser, Thomas Ammann
  • Publication number: 20030111405
    Abstract: The invention relates to a filter cloth for a filter press and to a method for producing said filter cloth. The inventive filter cloth has a filtration section through which the filtrate reaches a filter element of the filter press, and an edging section which rests against the edge of the filter element. The filtration area is provided with a cloth that differs from that of the edging section. The filtration area is woven from monofil yarns while multifil yarns are woven into the edging section.
    Type: Application
    Filed: November 18, 2002
    Publication date: June 19, 2003
    Inventors: Hans Rudolf Mueller, Christoph Maurer
  • Patent number: 6407237
    Abstract: The bifunctional compound N-4-carboxyphenyl-3-(6-oxohydropurin-9-yl) propanamide monopotassium salt occurs in a number of crystal forms which differ in their stability. Of these forms, the most stable is designated Type I, which is a monopotassium salt monohydrate in which the water is held as water of crystallization. Other crystalline forms, designated Type II and Type III, convert to Type I. Methods are disclosed for the synthesis of Type I and for the conversion of Type II or Type III to Type I.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: June 18, 2002
    Assignee: NeoTherapeutics, Inc.
    Inventors: Alvin J. Glasky, Heinrich Bollinger, Hans Rudolf Müller
  • Patent number: 6271374
    Abstract: Pure and extremely stable crystalline (6S)- and (6R)-tetrahydrofolic acids, absolutely inert even when exposed to air and elevated temperature without stabilizers being added, are prepared by a crystallization process at a pH of ≧3.5 for the preparation of crystalline (6S)-tetrahydrofolic acid and at a pH of ≧2 for the preparation of crystalline (6R)-tetrahydrofolic acid.
    Type: Grant
    Filed: January 26, 1998
    Date of Patent: August 7, 2001
    Assignee: Eprova AG
    Inventors: Hans Rudolf Müller, Martin Ulmann, Rudolf Moser, Thomas Ammann
  • Patent number: 6194600
    Abstract: With the present method, a process which can be employed industrially can be used for the first time for the direct production of aminocyanoacetamide. The method is based on the reaction of cyanoacetamide with nitrites to form nitrosocyanoacetamide at a pH of around 2 and on the subsequent catalytic hydrogenation of nitrosocyanoacetamide to form aminocyanoacetamide.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: February 27, 2001
    Assignee: Eprova A.G.
    Inventors: Hans Rudolf Müller, Heinrich Bollinger, Peter Schwaninger, Martin Kurz
  • Patent number: 6160116
    Abstract: The invention relates to a process for preparing (6S)-folinic acid and its salts by recrystallization of alkaline-earth salts of (6R,S)-folinic acid and, where necessary, liberation of the acid from the alkaline-earth folinates and/or, where necessary, conversion into the alkali salts by at least one recrystallization in the presence of a base. The invention also relates to calcium-, magnesium-, potassium- and sodium-(6S)-folinates and to (6S)-folinic acid prepared in accordance with the invention.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 12, 2000
    Assignee: Eprova A.G.
    Inventors: Hans Rudolf Mueller, Martin Ulmann, Josef Conti, Gunter Muerdel
  • Patent number: 4602089
    Abstract: There are prepared compounds of the formulae ##STR1## where R is lower alkyl, chlorine, or bromine and n is an integer from 1 to 5. The compounds of formula (1) can be used to make erythro-9-(2-hydroxy-3-nonyl) hypoxanthine and its homologues and also to make the compounds of formulae (2) and (3). All three classes of compounds are useful as immunomodulators.
    Type: Grant
    Filed: February 21, 1984
    Date of Patent: July 22, 1986
    Assignee: Newport Pharmaceuticals, Inc.
    Inventors: Lionel N. Simon, Hans-Rudolf Mueller, Hans Zutter
  • Patent number: 4451478
    Abstract: There are prepared compounds of the formulae ##STR1## where R is lower alkyl, chlorine, or bromine and n is an integer from 1 to 5. The compounds of formula (1) can be used to make erythro-9-(2-hydroxy-3-nonyl) hypoxanthine and its homologues and also to make the compounds of formulae (2) and (3). All three classes of compounds are useful as immunomodulators.
    Type: Grant
    Filed: March 12, 1982
    Date of Patent: May 29, 1984
    Assignee: Newport Pharmaceuticals International, Inc.
    Inventors: Lionel N. Simon, Hans-Rudolf Mueller, Hans Zutter
  • Patent number: 4189591
    Abstract: The yield of 4-methyl-5-hydroxymethyl-imidazole from the known reaction between formaldehyde and 4-methyl-imidazole can be increased greatly if the reaction is performed in a concentrated aqueous medium at pH 11-13.5, preferably 12-13.5, at a temperature of 20.degree.-60.degree. C., preferably 30.degree.-40.degree. C., with an amount of formaldehyde not exceeding 1.5 mole per mole of 4-methyl-imidazole.
    Type: Grant
    Filed: January 25, 1979
    Date of Patent: February 19, 1980
    Assignee: Eprova Aktiengesellschaft
    Inventors: Hans-Rudolf Mueller, Werner Kuendig, Alfred Hedinger